FBLN3 anticorps (AA 26-213)

N° du produit ABIN7428698

Détail du produit anti-FBLN3 anticorps

Antigène: FBLN3 (Fibulin 3 (FBLN3))

Épitope: AA 26-213

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp FBLN3 est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)

Fonction: Monoclonal Antibody to Fibulin 3 (FBLN3)

Specificité: The antibody is a mouse monoclonal antibody raised against FBLN3. It has been selected for its ability to recognize FBLN3 in immunohistochemical staining and western blotting.

Réactivité croisée: Porc, Rat

Purification: Protein A + Protein G affinity chromatography

Immunogène: Recombinant Fibulin 3 (FBLN3) corresdonding to Tyr26~Val213

Clone: C1

Isotype: IgG1 kappa

Information d'application

Indications d'application:

Western blotting: 0.5-5 μg/mL

Immunohistochemistry: 5-50 μg/mL

Immunocytochemistry: 5-50 μg/mL

Optimal working dilutions must be determined by end user.

Commentaires:

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.

Date de péremption: 24 months

Détails sur FBLN3

Antigène: FBLN3 (Fibulin 3 (FBLN3))

Autre désignation: Fibulin 3 (FBLN3 Produits)

Synonymes: anticorps DHRD, anticorps DRAD, anticorps FBLN3, anticorps FBNL, anticorps FIBL-3, anticorps MLVT, anticorps MTLV, anticorps S1-5, anticorps T16, anticorps EGF containing fibulin like extracellular matrix protein 1, anticorps EGF-containing fibulin-like extracellular matrix protein 1, anticorps epidermal growth factor-containing fibulin-like extracellular matrix protein 1, anticorps EFEMP1, anticorps Efemp1

Sujet: EFEMP1, DHRD, DRAD, FBNL, MLVT, MTLV, S1-5, EGF-Containing Fibulin-Like Extracellular Matrix Protein 1, Fibrillin-Like, Extracellular protein S1-5

Pathways: EGFR Signaling Pathway